BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33467494)

  • 1. Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study.
    Villavicencio A; Solans M; Zacarías-Pons L; Vidal A; Puigdemont M; Roncero JM; Saez M; Marcos-Gragera R
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study.
    Steingrímsson V; Lund SH; Dickman PW; Weibull CE; Björkholm M; Landgren O; Kristinsson SY
    Eur J Haematol; 2022 Feb; 108(2):145-153. PubMed ID: 34714556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
    Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
    JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study.
    Strati P; Parikh SA; Chaffee KG; Kay NE; Call TG; Achenbach SJ; Cerhan JR; Slager SL; Shanafelt TD
    Br J Haematol; 2017 Aug; 178(3):394-402. PubMed ID: 28580636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death.
    Rotbain EC; Niemann CU; Rostgaard K; da Cunha-Bang C; Hjalgrim H; Frederiksen H
    Leukemia; 2021 Sep; 35(9):2570-2580. PubMed ID: 33603143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain.
    Solans M; Osca-Gelis G; Comas R; Roncero JM; Gallardo D; Marcos-Gragera R; Saez M
    Cancer Causes Control; 2018 Mar; 29(3):379-382. PubMed ID: 29383469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study.
    Duchesneau ED; McNeill AM; Schary W; Pate V; Lund JL
    J Geriatr Oncol; 2023 Nov; 14(8):101602. PubMed ID: 37696241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model.
    Gordon MJ; Kaempf A; Sitlinger A; Shouse G; Mei M; Brander DM; Salous T; Hill BT; Alqahtani H; Choi M; Churnetski MC; Cohen JB; Stephens DM; Siddiqi T; Rivera X; Persky D; Wisniewski P; Patel K; Shadman M; Park B; Danilov AV
    Clin Cancer Res; 2021 Sep; 27(17):4814-4824. PubMed ID: 34168050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of chronic lymphocytic leukemia comorbidity index in a young population: a real-world evidence study of a national gulf region cohort.
    Alshemmari SH; AlSarraf A; Kaempf A; Danilov AV
    BMC Cancer; 2024 May; 24(1):584. PubMed ID: 38741031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumption of Ultra-Processed Food and Drinks and Chronic Lymphocytic Leukemia in the MCC-Spain Study.
    Solans M; Fernández-Barrés S; Romaguera D; Benavente Y; Marcos-Gragera R; Gracia-Lavedan E; Costas L; Robles C; Gonzalez-Barca E; de la Banda E; Alonso E; Aymerich M; Campo E; Llorca J; Fernández-Tardón G; Olmedo-Requena R; Gimeno E; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; de Sanjose S; Amiano P; Casabonne D
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34065213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization.
    Di Iorio B; Cillo N; Cirillo M; De Santo NG
    Int J Artif Organs; 2004 Apr; 27(4):330-6. PubMed ID: 15163067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis.
    Call TG; Phyliky RL; Noël P; Habermann TM; Beard CM; O'Fallon WM; Kurland LT
    Mayo Clin Proc; 1994 Apr; 69(4):323-8. PubMed ID: 8170175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: A population-based study.
    Michalopoulou E; Matthes KL; Karavasiloglou N; Wanner M; Limam M; Korol D; Held L; Rohrmann S
    Cancer Epidemiol; 2021 Aug; 73():101962. PubMed ID: 34051687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib.
    Gordon MJ; Churnetski M; Alqahtani H; Rivera X; Kittai A; Amrock SM; James S; Hoff S; Manda S; Spurgeon SE; Choi M; Cohen JB; Persky D; Danilov AV
    Cancer; 2018 Aug; 124(15):3192-3200. PubMed ID: 29797667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of comorbidity for patients with chronic lymphocytic leukemia].
    Emelina EI; Gendlin GE; Nikitin IG; Poddubnaia IV; Udin AA; Dmitrieva EA
    Kardiologiia; 2018 SOct; (S10):51-60. PubMed ID: 30362429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia.
    Vojdeman FJ; Van't Veer MB; Tjønnfjord GE; Itälä-Remes M; Kimby E; Polliack A; Wu KL; Doorduijn JK; Alemayehu WG; Wittebol S; Kozak T; Walewski J; Abrahamse-Testroote MC; van Oers MH; Geisler CH
    Leuk Lymphoma; 2017 Mar; 58(3):594-600. PubMed ID: 27484290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic characterization and multivariate survival analysis of chronic lymphocytic leukemia in Taiwan.
    Chen PM; Lin SH; Fan SF; Chiou TJ; Hsieh RK; Yu IT; Liu JH
    Acta Haematol; 1997; 97(4):196-204. PubMed ID: 9158661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.
    Mozessohn L; Earle C; Spaner D; Cheng SY; Kumar M; Buckstein R
    J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of the Modified Charlson Comorbidity Index in Incident Peritoneal Dialysis Patients: A National Population-Based Approach.
    Cho H; Kim MH; Kim HJ; Park JY; Ryu DR; Lee H; Lee JP; Lim CS; Kim KH; Oh KH; Joo KW; Kim YS; Kim DK
    Perit Dial Int; 2017 1-2; 37(1):94-102. PubMed ID: 27605681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
    Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
    BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.